RxDoctor Payments Data

Jewel Stevens

Family Medicine · Carlisle, OHNPI 1316921067

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 1,190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,406in general payments, 2019–2025

Across 1,190 payments — averaging $13.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Pfizer$1K
  • Astellas Pharma US Inc$776
  • Lilly USA, LLC$754
  • plus $8K from 54 others
$7,027in research payments, 2019–2025

Across 4 payments — averaging $1756.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$4K
  • Merck$3K

What the payments were for

  • Food & beverage$16,19199%
  • Education$2151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)106$2,336
AbbVie(2 entities)217$2,003
Novo Nordisk108$1,252
Pfizer92$1,072
Astellas Pharma US Inc36$776
Lilly USA, LLC59$754
Amgen52$753
Johnson & Johnson56$634
Takeda Pharmaceuticals U.S.A., Inc.41$588
Bayer49$486
Boehringer Ingelheim31$449
Sanofi-aventis U.S. LLC33$439
Merck32$432
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC26$377
Novartis21$298
GSK17$290
Mylan Specialty L.p.16$285
Otsuka America Pharmaceutical, Inc.13$207
Biohaven Pharmaceutical Holding Company Ltd.16$195
Kowa Pharmaceuticals America, Inc.14$187
Amarin Pharma, Inc.12$180
Dexcom, Inc.7$157
Sun Pharmaceutical Industries Inc.2$150
Biohaven Pharmaceuticals, Inc.13$144
Abbott7$136
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$130
Exact Sciences6$121
Lundbeck LLC6$103
Upsher-smith Laboratories LLC6$102
Supernus Pharmaceuticals, Inc.6$99
Renalytix AI, Inc.6$95
Sunovion Pharmaceuticals Inc.5$85
Sumitomo Pharma America, Inc.4$84
Nestle Healthcare Nutrition Inc.6$79
Seqirus USA Inc4$73
Teva Pharmaceuticals USA, Inc.5$63
Verona Pharma, Inc.3$59
Eisai Inc.4$58
Viatris Specialty LLC3$54
Biogen3$44
Jazz Pharmaceuticals Inc.2$43
Circassia Inc.3$36
Axsome Therapeutics, Inc.2$34
Collegium Pharmaceutical, Inc.2$33
Xeris Pharmaceuticals, Inc.2$32
Electromed, Inc.4$28
Zyla Life Sciences, Inc.2$26
Biodelivery Sciences International, Inc.2$24
Ultragenyx Pharmaceutical Inc.1$24
E.r. Squibb & Sons, L.L.C.2$24
Boston Scientific1$22
Organon1$20
Amphastar Pharmaceuticals, Inc.1$20
Therapeuticsmd, Inc.1$20
Bausch Health US, LLC1$17
Sanofi Pasteur Inc.1$17
Aimmune Therapeutics, Inc.1$16
Idorsia Pharmaceuticals US Inc1$16
Shionogi Inc1$16
Corium, LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,406 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol36$37,305
OzempicSemaglutide22$22,381
TrulicityDulaglutide12$20,369
VraylarCariprazine Hcl11$19,521
JardianceEmpagliflozin14$18,903
MounjaroTirzepatide12$14,605
EliquisApixaban13$11,867
Ondansetron Hcl21$8,392
Albuterol Sulfate HfaAlbuterol Sulfate64$1,652
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,499
Colestipol Hcl12$1,163
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$809
Duloxetine Hcl48$793
Pregabalin29$789
Omeprazole74$770

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$2,336$37,30536 claims
Lilly USA, LLCTrulicity, Mounjaro$754$34,97424 claims
Novo NordiskOzempic$1,252$22,38122 claims
AbbVieVraylar$2,003$19,52111 claims
Boehringer IngelheimJardiance$449$18,90314 claims
PfizerEliquis$1,072$11,86713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Carlisle

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →